唑来膦酸治疗播散性前列腺癌

Zometa in the treatment of diseminated prostate cancer.

作者信息

Djokic M

机构信息

Institute of Urology and Nephrology, Clinical Center of Serbia, Belgrade.

出版信息

Acta Chir Iugosl. 2005;52(4):119-21. doi: 10.2298/aci0504119d.

DOI:10.2298/aci0504119d

PMID:16673608

Abstract

Zoledronic acid is the first bisphosphonat that confirms the a efficacy in the treatment of bone metastases in prostate carcinoma. That is the most potent bisphosphonat up to date which safe and simple administration. Zometa is strong inhibitor of osteoclast activity.

摘要

唑来膦酸是第一种证实对前列腺癌骨转移治疗有效的双膦酸盐。它是目前最有效的双膦酸盐，给药安全且简便。择泰是破骨细胞活性的强效抑制剂。